ATHERO52, A Proof of Concept Device Design to Remove and Treat Atherosclerosis with a Non-Invasive Surgical Approach
Author
Eden, Devereaux Linnea
Metadata
Show full item recordCitation
Eden, Devereaux Linnea. 2021. ATHERO52, A Proof of Concept Device Design to Remove and Treat Atherosclerosis with a Non-Invasive Surgical Approach. Master's thesis, Harvard University Division of Continuing Education.Abstract
Atherosclerosis, associated with coronary artery disease (CAD) contributes to oneof the largest reasons for deaths worldwide in 2017 (Center for Disease Control and
Prevention [CDC], 2019a). Commercialized devices on the market focus primarily on the
treatment of peripheral artery disease (PAD) rather than CAD (Fornell, D., 2020, January
3). Divulging into the knowledge of previous atherectomy devices RotaPRO (Boston
Scientific), Pantheris (Avinger), TurboHawk (Medtronic) and Jetstream Atherectomy
(Boston Scientific), SilverHawk (Medtronic), Diamond Back 360 Coronary Orbital
Atherectomy System (Cardiovascular Systems) and CVX-300 Excimer Laser System
(Spectranetics) each contribute in some way to the inspiration and design of ATHERO52.
(Topfer LA & Spry C., 2018, April 1). The goal of this research facilitates creation of a
medical device for the coronary artery atherectomy system that incorporates both new
and former technologies to provide a minimally invasive approach and safe treatment for
patients with CAD. ATHERO52 takes on a fresher approach in atherectomy systems with
the use of optical coherence tomography (OCT) to better visualize the inside of the
arteries during the procedure. Inspired by Pantheris (Avinger, 2020) ATHERO52
incorporates two OCT imaging sensors to provide a clear visual representation for the
location of healthy tissue layers when navigating and performing plaque removal in the
vessels. OCT reduces the potential proliferation of tissue along the vessel wall when
extracting plaque. In addition, with much research ATHERO52 includes the use of
directionality steering to eliminate the need of a guidewire housed within the device and
promotes a greater level of safety and efficacy. Research uncovers guidewires on several
devices such as the Diamond Back 360 Orbital Atherectomy System experiencing difficulties in placement and removal resulting in harm to the patient (U.S. FDA, 21,
August 2018). Lastly, ATHERO52 addresses the necessity for a plaque removal
component that is employed along the pathway to the target site with the use of a
forward-facing cutter. The forward-facing cutter permits the operator to generate a clear
path to the target site while also enabling easier extraction of the system when the
procedure is complete. The design of this device eradicates harmful components found
on previous systems, shortens procedure and recovery time while focusing on a prevalent
disease that affects individuals worldwide.
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37367706
Collections
- DCE Theses and Dissertations [1264]
Contact administrator regarding this item (to report mistakes or request changes)